New and updated guidance issued by NICE on a range of topics, including COVID-19 November 2020 NICE has issued a number of new and updated guidelines on a range of topics, including COVID-19. In its series of COVID-19 rapid guidelines, NICE […]
NICE publishes two technology appraisals on osimertinib for non-small-cell lung cancer November 2020 NICE has published Technology Appraisal (TA) Guidance 653 and 654 on osimertinib for the treatment of non-small-cell lung cancer (NSCLC). TA653, Osimertinib for treating EGFR […]
COVID matters report: urgent lung cancer specialist referrals down 75% in the first wave November 2020 The UK Lung Cancer Coalition has published a report describing the effect of the COVID-19 pandemic on lung cancer referrals, COVID-19 matters—a review of the […]
Interview: Professor David Cunningham November 2020 | By Alastair Whitington In this short video, Professor David Cunningham, Consultant Medical Oncologist at the The Royal Marsden NHS Foundation Trust and Chair of the Association of Cancer […]
Restarting cancer services will require stratification and coordination November 2020 | By Nina Buchan As part of the Virtual UK Oncology Forum 2020, The Big COVID/Cancer Debate took place online on 25 September 2020. This fringe meeting, which was […]
A risk-stratified approach to planned cancer care during the COVID-19 pandemic October 2020 NICE has published A risk-stratified approach to planned cancer care during the COVID-19 pandemic: the Royal Marsden experience. The report describes a review of the planned cancer […]
